Participations à des congrès et colloques internationaux (64)
61.
Van Antwerpen, P., Zouaoui Boudjeltia, K., Legssyer, I., Babar, S., Moreau, P., Moguilevsky, N., Vanhaeverbeek, M., Ducobu, J., & Neve, J. (2005). Comparative assessment of the inhibiting effect of captopril and of 4 antagonists of the angiotensin converting enzyme on LDL oxidation by the myeloperoxidase. In Atherosclerosis Supplement: Vol. 6 (pp. 81-82) Elsevier.62.
Zouaoui Boudjeltia, K., Legssyer, I., Van Antwerpen, P., Babar, S., Guillaume, M., Moguilevsky, N., Vanhaeverbeek, M., Ducobu, J., & Brohée, D. (2005). Myeloperoxidase-modified (MOX) LDL induce the production of IL-8 by endothelial cells in contrast to MOX-albumin. In Atherosclerosis Supplements: Vol. 6 (p. 84) Elsevier.63.
Van Antwerpen, P., Zouaoui Boudjeltia, K., Babar, S., Lessgyer, I., Moreau, G., Moguilesvsky, N., Vanhaeverbeek, M., & Neve, J. (2004). LDL oxidation by the myeloperoxydase/H2O2/Cl- system is inhibited by various thiol-containing molecules. Poster présenté à la conférence 187th meeting of the Belgian Society of Biochemistry and Molecular Biology, together with the FNRS contact group on oxidative stress and antioxidants (14 mai 2004: Liège, Belgique).64.
Van Antwerpen, P., Zouaoui Boudjeltia, K., Babar, S., Legssyer, I., Moreau, G., Moguylevsky, N., Vanhaeverbeek, M., & Neve, J. (2004). Thiol-containing molecules directy interact with myeloperoxidase to inhibit LDL-Oxidation by the MPO system. Poster présenté à la conférence DALM 2004, 15th International Symposium on Drugs Affecting Lipid Metabolism (24-27 septembre 2004: Venise, Italie). Brevets (3)
Thèses et mémoires (1)
Participation aux jurys de thèse (2)